, Tracking Stock Market Picks
Enter Symbol:
Dusa Pharmaceuticals, Inc. (DUSA) [hlAlert]

up 59.04 %

Dusa Pharmaceuticals, Inc. (DUSA) rated Buy with price target $9.50 by C.K. Cooper

Posted on: Thursday,  Nov 8, 2012  10:25 AM ET by C.K. Cooper

C.K. Cooper rated Buy Dusa Pharmaceuticals, Inc. (NASDAQ: DUSA) on 11/08/2012. Previously C.K. Cooper rated Buy Dusa Pharmaceuticals, Inc. (NASDAQ: DUSA) on
03/06/2012., when the stock price was $5.03. Since then, Dusa Pharmaceuticals, Inc. has gained 59.05% as of 12/20/2013's recent price of $8.00.
If you would have followed the previous C.K. Cooper's recommendation on DUSA, you would have gained 59.04% of your investment in 654 days.

DUSA Pharmaceuticals, Inc. is a pharmaceutical company developing drugs in combination with light devices to treat or detect a variety of conditions in processes known as photodynamic therapy or photodetection. They are engaged primarily in the research and development of our first drug, the Levulan brand of aminolevulinic acid HCl with light, for use in a broad range of medical conditions.

C. K. Cooper & Company has for over a decade provided insightful research ideas and commentary. As the firm identifies focus industries it brings together an analytical team to provide unique vision and insight to select investment ideas. In addition, leveraging on the expertise of the firm, the Research Team can evaluate opportunities against a wide database of industry and competitive trends.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/8/2012 10:25 AM Buy
7.97 9.50
as of 12/31/2012
1 Week   
1 Month up  0.37 %
3 Months up  17.82 %
1 YTD up  0.37 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/6/2012 8:25 AM Buy
5.03 8.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy